Kenji Shimizu

11.1k citations

221 papers · 8.9k indexed · 2 hit papers · h-index 48

Oncology top 0.5%
- Cancer-related Molecular Pathways 16
- Cancer Immunotherapy and Biomarkers 11
Cancer Research top 1%
Immunology top 1%
- Immune Cell Function and Interaction 21
Molecular Biology top 1%
- RNA modifications and cancer 38
- Cancer-related gene regulation 28
- Epigenetics and DNA Methylation 12
- DNA Repair Mechanisms 11
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer 12

Co-authors: Mitchell Goldfarb Michael Wigler Mamoru Ouchida Elizabeth J. Taparowsky Manuel Perucho Takumi Maruhashi Taku Okazaki Il‐mi Okazaki
Cited by: Oncology Cancer Research Immunology
Journals: Nature (2 papers)Science (1 paper)Cell (2 papers)
Partner nations: Japan United States China

In The Last Decade

Kenji Shimizu

211 papers receiving 8.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Kenji Shimizu

Since Specialization

Citations

This map shows the geographic impact of Kenji Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Shimizu more than expected).

Fields of papers citing papers by Kenji Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Shimizu. The network helps show where Kenji Shimizu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kenji Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kenji Shimizu Line = papers co-authored together Kenji Shimizu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of 5’ untranslated region variants in genes involved in neurodevelopmental disorders Journal of Human Genetics ·Taiju Hayashi,Sachiko Miyamoto,Yusaku Endo,Kenji Shimizu,Yumiko Ohkubo,Kazuyuki Komatsu,Shogo Furukawa,Mitsuko Nakashima,Tokiko Fukuda,Tsutomu Ogata,Takuya Hiraide,Hirotomo Saitsu	2026	0
2	Efficacy and safety of intravenous fosphenytoin for patients with acute herpes zoster‐associated pain: A placebo‐controlled randomized trial The Journal of Dermatology ·Masako Iseki,Takenobu Yamamoto,Youichi Ogawa,Yuta Majima,Yoichiro Abe,Daisuke Watanabe,Fumimasa Amaya,Toshio Hasegawa,K. Inafuku,Toshifumi Kosugi,Yukiko Nomura,Tokiko Deguchi,Toshihisa Hamada,Kenji Shimizu,Saori Arai,Morito Takahashi,Izumi Hamada,Yuko Ishikawa,Makoto Kawashima	2023	2
3	Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity Immunity ·Takumi Maruhashi,Daisuke Sugiura,Il‐mi Okazaki,Kenji Shimizu,Takeo K. Maeda,Jun Ikubo,Harunori Yoshikawa,Katsumi Maenaka,Naozumi Ishimaru,Hidetaka Kosako,Tatsuya Takemoto,Taku Okazaki	2022	129
4	PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity Nature Immunology ·Daisuke Sugiura,Il‐mi Okazaki,Takeo K. Maeda,Takumi Maruhashi,Kenji Shimizu,Rieko Arakaki,Tatsuya Takemoto,Naozumi Ishimaru,Taku Okazaki	2022	57
5	Robotic data acquisition with deep learning enables cell image–based prediction of transcriptomic phenotypes Proceedings of the National Academy of Sciences ·Jianshi Jin,Taisaku Ogawa,Nozomi Hojo,Kirill Kryukov,Kenji Shimizu,Tomokatsu Ikawa,Tadashi Imanishi,Taku Okazaki,Katsuyuki Shiroguchi	2022	14
6	TARM1 contributes to development of arthritis by activating dendritic cells through recognition of collagens Nature Communications ·Rikio Yabe,Soo-Hyun Chung,Masanori A. Murayama,Sachiko Kubo,Kenji Shimizu,Yukiko Akahori,Takumi Maruhashi,Akimasa Seno,Tomonori Kaifu,Shinobu Saijo,Yoichiro Iwakura	2021	18
7	PD-1 preferentially inhibits the activation of low-affinity T cells Proceedings of the National Academy of Sciences ·Kenji Shimizu,Daisuke Sugiura,Il‐mi Okazaki,Takumi Maruhashi,Tatsuya Takemoto,Taku Okazaki	2021	14
8	Establishment of Novel High-Standard Chemiluminescent Assay for NTPase in Two Protozoans and Its High-Throughput Screening Marine Drugs ·Masamitsu Harada,Jun Nagai,Riho Kurata,Kenji Shimizu,Xiaofeng Cui,Takayuki Isagawa,Hiroaki Semba,Jun Ishihara,Yasuhiro Yoshida,Norihiko Takeda,Koji Maemura,Yonezawa Tomo	2020	4
9	Restriction of PD-1 function by cis -PD-L1/CD80 interactions is required for optimal T cell responses Science ·Daisuke Sugiura,Takumi Maruhashi,Il‐mi Okazaki,Kenji Shimizu,Takeo K. Maeda,Tatsuya Takemoto,Taku Okazaki	2019	285
10	Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota Nature Immunology ·Ce Tang,Shigeru Kakuta,Kenji Shimizu,Motohiko Kadoki,Tomonori Kamiya,Tomoyuki Shimazu,Sachiko Kubo,Shinobu Saijo,Harumichi Ishigame,Susumu Nakae,Yoichiro Iwakura	2018	132
11	LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII Nature Immunology ·Takumi Maruhashi,Il‐mi Okazaki,Daisuke Sugiura,Suzuka Takahashi,Takeo K. Maeda,Kenji Shimizu,Taku Okazaki	2018	202
12	Human RAD 17 Polymorphism at Codon 546 Is Associated with the Risk of Colorectal Cancer. PubMed ·Yukiko Yasuda,Akiko Sakai,Sachio Ito,Kaori Sasai,Hiromasa Yamamoto,Nagahide Matsubara,Mamoru Ouchida,Hiroshi Katayama,Kenji Shimizu	2017	3
13	Liposomal Delivery of MicroRNA-7–Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells Molecular Cancer Therapeutics ·Kammei Rai,Nagio Takigawa,Sachio Ito,Hiromi Kashihara,Eiki Ichihara,Tatsuji Yasuda,Kenji Shimizu,Mitsune Tanimoto,Katsuyuki Kiura	2011	110
14	Multi-Step Aberrant CpG Island Hyper-Methylation Is Associated with the Progression of Adult T–Cell Leukemia/Lymphoma American Journal Of Pathology ·Hiaki Sato,Takashi Oka,Yoko Shinnou,Takami Kondo,Kana Washio,Masayuki Takano,Katsuyoshi Takata,Toshiaki Morito,Xingang Huang,Maiko Tamura,Yuta Kitamura,Nobuya Ohara,Mamoru Ouchida,Koichi Ohshima,Kenji Shimizu,Mitsune Tanimoto,Kiyoshi Takahashi,Masao Matsuoka,Atae Utsunomiya,Tadashi Yoshino	2009	58
15	MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors International Journal of Cancer ·Takafumi Kubo,Hiromasa Yamamoto,William W. Lockwood,Ilse Valencia,Junichi Soh,Michael Peyton,Masaru Jida,Hiroki Otani,Tetsuya Fujii,Mamoru Ouchida,Nagio Takigawa,Katsuyuki Kiura,Kenji Shimizu,Hiroshi Date,John D. Minna,Marileila Varella‐Garcia,Wan L. Lam,Adi F. Gazdar,Shinichi Toyooka	2008	117
16	A Case of Laparotomy in Adult Henoch-Schoenlein Purpura with Chief Complaint of Abdominal Symptoms The Japanese Journal of Gastroenterological Surgery ·Kenji Shimizu,Akihito Nakanishi,Takashi Hayashi,Bunpei Sato,Masae Tsuji	2004	0
17	Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer. PubMed ·Ayman Elnemr,Tomohiko Ohta,M Kayahara,H Kitagawa,K Yoshimoto,Tohru Tani,Kenji Shimizu,G Nishimura,Tetsuya Terada,K Miwa	2001	22
18	TR-IA4号機特集 Transient Crystal Growth Rate in Microgravity:Report from TR-IA-4 Rocket Experiment K. Tsukamoto,Etsuo Yokoyama,Shuhei Maruyama,Koji Maiwa,Kenji Shimizu,S. Morita Tomoji,Shinichi Yoda	1998	0
19	Inhibition of growth of some enteropathogenic strains in mixed cultures of Streptococcus faecalis and Clostridium butyricum Genichiro Seo,Kenji Shimizu,Masanori Sasatsu,Midori Kono	1989	9
20	Isolation and Preliminary Characterization of the Chinese Hamster Thymidine Kinase Gene Molecular and Cellular Biology ·John A. Lewis,Kenji Shimizu,David Zipser	1983	38

About Kenji Shimizu

Kenji Shimizu is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 221 papers that have together received 8.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (38 papers), Cancer-related gene regulation (28 papers), Immune Cell Function and Interaction (21 papers), Cancer-related Molecular Pathways (16 papers), Genetic factors in colorectal cancer (12 papers), Epigenetics and DNA Methylation (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and DNA Repair Mechanisms (11 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (1.3k citations) and Immunology (1.6k citations). Kenji Shimizu has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Mitchell Goldfarb, Michael Wigler, Mamoru Ouchida, Elizabeth J. Taparowsky, Manuel Perucho, Takumi Maruhashi, Taku Okazaki, Il‐mi Okazaki, Daisuke Sugiura and Ottavio Fasano. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact